Navigation Links
Breakthrough Technology That Will Revolutionize the Treatment of Tooth Decay
Date:7/3/2008

he lab or in field trials," says Dr. Andreas Mandelis, Professor at the University of Toronto and President of Quantum Dental Technologies. "The technology is robust and will provide the researcher with a real-time view of the lesion without destruction of the tooth."

The Canary System will be in clinical trials for the next 18-24 months with collaborators in both research and clinical settings, and will be ready for market release in 2010.

About Quantum Dental Technologies

Quantum Dental Technologies is a new Canadian diagnostic device company focused on the field of oral health care. QDT has designed and developed The Canary Dental Caries Detection System, a patented technology, to provide patients with an alternative to the traditional "drill, fill and bill" approach to dental care. For more information, please visit http://www.thecanarysystem.com.


'/>"/>
SOURCE NATIONAL PharmaCom
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Breakthrough "Neuro Nutrition" Targets the Brain and Vagus Nerve To Boost the Body's Immune, Hormone and Neurological Systems
2. Breakthrough Coaching is Celebrating the Launch of Breakthrough Coaching TV
3. Solidica Awarded 2008 Best of Sensors Expo Honor for Breakthrough Battery Health Monitor
4. Breakthrough Isolaz(TM) Acne Therapy Featured in U.S. News & World Report:
5. A New Home for Medical Breakthroughs
6. Yales Scassellati gets Microsoft breakthrough research award for robotics
7. Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment
8. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
9. Dental Convention to Highlight Latest Breakthroughs in Oral Health Treatments
10. Medical Breakthrough Reaches America
11. Tiny magnets offer breakthrough in gene therapy for cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 2AMP Receives $1.4 Million Grant From the Bill & Melinda Gates Foundation to Improve Advocacy for VACCINES and Immunization Systems in West Africa 3Pharmacy Technician Employment Increasing Up to 32% By 2016 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6HMS Holdings Corp to Present at William Blair 29th Annual Growth Stock Conference 48209 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 1Toms of Maine Invites Public Participation in 50 States for Good Program 48207 2University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 1University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 2University of Michigan Installs Neuro Kinetics I Portal 28R 29 NOTC System 12527 3